T. Rowe Price Investment Management’s BrightSpring Health Services BTSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$421M Sell
6,041,971
-1,587,180
-21% -$88.1M 0.28% 90
2026
Q1
$325M Buy
7,629,151
+1,505,286
+25% +$60.6M 0.22% 110
2025
Q4
$229M Buy
6,123,865
+1,091,757
+22% +$36.6M 0.14% 156
2025
Q3
$149M Buy
5,032,108
+138,708
+3% +$3.22M 0.09% 217
2025
Q2
$115M Sell
4,893,400
-879,372
-15% -$18.3M 0.07% 256
2025
Q1
$104M Buy
5,772,772
+4,189,805
+265% +$82.3M 0.07% 269
2024
Q4
$27M Buy
+1,582,967
New +$27.4M 0.02% 491

Other funds holding BTSG

T. Rowe Price Investment Management's BTSG Position: Q2 2026 in Review

T. Rowe Price Investment Management reduced its BrightSpring Health Services (BTSG) stake by 21% in Q2 2026, selling an estimated $88.1M and leaving 6,041,971 shares worth $421M. The position accounts for 0.28% of the portfolio, ranked #90.

T. Rowe Price Investment Management first reported a position in BTSG in Q4 2024 and has held it in 7 quarters since. 422 funds tracked by Wall St. Rank hold BTSG as of Q2 2026.

  • T. Rowe Price Investment Management held 6,041,971 shares of BrightSpring Health Services worth $421M as of Q2 2026.
  • T. Rowe Price Investment Management sold 1,587,180 BrightSpring Health Services shares in Q2 2026, an estimated $88.1M.
  • BrightSpring Health Services made up 0.28% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #90 holding.
  • T. Rowe Price Investment Management first reported a position in BrightSpring Health Services in Q4 2024 and has held it in 7 quarters since.
  • 422 funds tracked by Wall St. Rank held BrightSpring Health Services as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.